ARK Investment Management LLC 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-11 2:21 pm Purchase | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | ARK Investment Management LLC | 15,297,822 10.430% | 15,297,822 (New Position) | Filing |